BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Derycz Scientific (DYSE) Subsidiary Expands Into Japan Through Referral Agreement with USACO Corporation


6/1/2011 10:27:37 AM

SANTA MONICA, Calif., June 1, 2011 /PRNewswire/ -- Derycz Scientific, Inc.(OTC BB: DYSC) today announced that wholly-owned subsidiary Reprints Desk, Inc. has signed a master referral agreement with Tokyo-based USACO Corporation. The agreement makes USACO the Japanese representative for Reprints Desk's article supply system and services used by companies in Life Sciences and other intellectual property (IP)-based businesses. Terms of the deal were not released.

"Derycz Scientific is honored to be able to serve Japanese customers with support from USACO Corporation, a respected service provider with more than 70 years history in providing quality scientific literature solutions in Japan in support of research, information management, and regulatory-compliant sales and marketing," said Derycz Scientific Chief Executive Officer Peter Derycz. "As the world's second-largest pharmaceutical market and home for many of the world's largest revenue-generating corporations, we believe that our entry into the Japanese market will be very successful for Japanese customers, Derycz Scientific, and USACO."

USACO Corporation is a private information services company that links and networks societies and publishers with library and research customers through access to journals, books, database and documents in print and electronic formats. The company, founded as Yamakawa & Company in 1934, is led by President and Chief Executive Officer Mr. Shinichi Yamakawa.

"USACO looks forward to actively introducing Reprints Desk to current and future customers, and transforming the Japanese market by leading the shift from paper to digital document delivery service," said USACO's Yamakawa. "Japanese companies who transition to Reprints Desk will realize many benefits, including faster delivery in support of their critical research."

Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG).

For more information about Derycz Scientific, visit www.deryczscientific.com.

About Derycz Scientific®

Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, with services designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces and newsletters; and works with publishers who wish to outsource a portion of or all of their reprints business. TAAG offers printing, distribution and information logistics services, with core competencies in the professional production and distribution of clinical trial kits and clinical article reprints for the life sciences industry. For more information, please visit www.deryczscientific.com.

About Reprints Desk®

Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.

About USACO

USACO Corporation contributes to evolution of the scientific community in Japan. Since its origin as Yamakawa & Company in 1934, the company has worked closely with scientists and information specialists in universities, governments, research institutes and corporate research institutions. Customers trust USACO Corporation for help finding information, managing knowledge and developing new ideas.

Forward-Looking Statements

Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.

SOURCE Derycz Scientific, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES